Table 1.
Clinical characteristics of PAAD patients in TCGA database.
| Characteristics | Levels | Overall |
|---|---|---|
| n | 178 | |
| T stage, n (%) | T1 | 7 (4%) |
| T2 | 24 (13.6%) | |
| T3 | 142 (80.7%) | |
| T4 | 3 (1.7%) | |
|
| ||
| N stage, n (%) | N0 | 50 (28.9%) |
| N1 | 123 (71.1%) | |
|
| ||
| M stage, n (%) | M0 | 79 (94%) |
| M1 | 5 (6%) | |
|
| ||
| Pathological stage, n (%) | Stage I | 21 (12%) |
| Stage II | 146 (83.4%) | |
| Stage III | 3 (1.7%) | |
| Stage IV | 5 (2.9%) | |
|
| ||
| Gender, n (%) | Female | 80 (44.9%) |
| Male | 98 (55.1%) | |
|
| ||
| Age, n (%) | ≤65 | 93 (52.2%) |
| >65 | 85 (47.8%) | |
|
| ||
| Histological grade, n (%) | G1 | 31 (17.6%) |
| G2 | 95 (54%) | |
| G3 | 48 (27.3%) | |
| G4 | 2 (1.1%) | |
|
| ||
| OS event, n (%) | Alive | 86 (48.3%) |
| Dead | 92 (51.7%) | |
|
| ||
| DSS event, n (%) | Alive | 100 (58.1%) |
| Dead | 72 (41.9%) | |
T stage, primary tumor size; N stage, regional lymph nodes; M stage, distant metastasis; OS, overall survival; DSS, disease specific survival.